Patents by Inventor Hsiang-Ching Wang

Hsiang-Ching Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOSTIMULATORY LIPOPLEX, PHARMACEUTICAL COMPOSITION INCLUDING IMMUNOSTIMULATORY LIPOPLEX, AND USES THEREOF
    Publication number: 20220202952
    Abstract: An immunostimulatory lipoplex is provided. The immunostimulatory lipoplex includes a liposome and at least one immunostimulatory nucleic acid drug, and the immunostimulatory nucleic acid drug is complexed with the liposome The liposome includes 40 to 85 mol % of cationic lipid, 10 to 50 mol % of cholesterol, and 0.001 to 20 mol % of modified polyethylene glycol lipid.
    Type: Application
    Filed: December 23, 2021
    Publication date: June 30, 2022
    Applicant: Industrial Technology Research Institute
    Inventors: Neng-Chang YU, Felice CHENG, Chih-Peng LIU, Ming-Hsi WU, Shih-Ta CHEN, Chia-Mu TU, Li-Wen CHANG, Jheng-Sian LI, Meng-Ping SHE, Hsiang-Ching WANG
  • Anti-human epidermal growth factor receptor antibody and uses thereof
    Patent number: 8758756
    Abstract: An anti-human epidermal growth factor receptor (EGFR) antibody including an amino acid sequence as set forth in SEQ ID No. 3 is provided. The antibody binding to a labeling agent and used for labeling cells is also provided. A novel method for screening an anti-EGFR antibody is further provided.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: June 24, 2014
    Assignee: Industrial Technology Research Institute
    Inventors: Hsiang-Ching Wang, Ming-Hua Yang, Ling-Mei Wang, Min-Yuan Chou, Jyuan-Jyuan Syu
  • Anti-human transferrin receptor antibody and uses thereof
    Patent number: 8663598
    Abstract: One embodiment of the disclosure provides an amino sequence of an anti-human transferrin receptor antibody, including: an amino sequence of a heavy chain variable region which is represented by SEQ ID NO.: 1 or SEQ ID NO.: 2, wherein the anti-human transferrin receptor antibody is capable of specifically binding to a human transferrin receptor.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: March 4, 2014
    Assignee: Industrial Technology Research Institute
    Inventors: Ming-Hua Yang, Min-Yuan Chou, Hsiang-Ching Wang
  • ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODY AND USES THEREOF
    Publication number: 20130171061
    Abstract: One embodiment of the disclosure provides an amino sequence of an anti-human transferrin receptor antibody, including: an amino sequence of a heavy chain variable region which is represented by SEQ ID NO.: 1 or SEQ ID NO.: 2, wherein the anti-human transferrin receptor antibody is capable of specifically binding to a human transferrin receptor.
    Type: Application
    Filed: September 11, 2012
    Publication date: July 4, 2013
    Inventors: Ming-Hua YANG, Min-Yuan Chou, Hsiang-Ching Wang
  • ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY AND USES THEREOF
    Publication number: 20130171174
    Abstract: An anti-human epidermal growth factor receptor (EGFR) antibody including an amino acid sequence as set forth in SEQ ID No. 3 is provided. The antibody binding to a labeling agent and used for labeling cells is also provided. A novel method for screening an anti-EGFR antibody is further provided.
    Type: Application
    Filed: September 12, 2012
    Publication date: July 4, 2013
    Inventors: Hsiang-Ching WANG, Ming-Hua Yang, Ling-Mei Wang, Min-Yuan Chou, Jyuan-Jyuan Syu